Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Because AOD9604 does not stimulate IGF-1 production and lacks strong GH receptor agonism, it may present a safer alternative for long-term OA treatment [1]
See our BPC-157 vs TB-500 comparison for more details
:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)
It is typically not recommended for self-administration due to the smaller muscle mass compared to other sites
Nausea affects approximately 44% of participants in pooled STEP trial data, with diarrhea (30%), vomiting (24%), and constipation (24%) also common
Others take days to notice changes
US$ 28.02
US$ 29.10
US$ 28.09
US$ 22.67
US$ 26.63
